We are pleased to see this litigation moving forward. We continue to hear from Biomet hip replacement recipients who have suffered serious complications, allegedly due to the Biomet M2a Magnum hip replacement.
New York, NY (PRWEB) May 15, 2013
The federal Biomet hip lawsuit consolidated litigation underway in U.S. District Court, Northern District of Indiana, continues to move forward, Bernstein Liebhard LLP reports. According to a Joint Stipulation issued on May 14th, the parties have agreed to the dismissal of all “improper defendants,” in the litigation, including all “John Does” and all but four Biomet entities: Biomet Inc.; Biomet Orthopedics LLC; Biomet Manufacturing Corp.; and Biomet U.S. Reconstruction LLC. In an Order dated May 3rd, U.S. District Judge Robert L. Miller Jr. also directed that Biomet corporate depositions be conducted at locations in either South Bend or Fort Wayne, Ind., both of which are within easy reach of Biomet’s headquarters. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation - MDL No. 2391)
“We are pleased to see this litigation moving forward. We continue to hear from Biomet hip replacement recipients who have suffered serious complications, allegedly due to the Biomet M2a Magnum hip replacement. We expect many more Biome hip replacement lawsuits to be filed in this proceeding in the future,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently representing Biomet hip lawsuit clients in the federal multidistrict litigation, and continues to offer free legal evaluations to individuals allegedly injured by the Biomet M2a hip.
Biomet Hip Replacement Lawsuits
According to court documents, more than 140 Biomet hip replacement lawsuits have been filed in Indiana. The U.S. Judicial Panel on Multidistrict Litigation ordered the transfer of all federally-filed Biomet hip lawsuits to the Northern District of Indiana in October 2012. All of the complaints pending in the litigation share similar allegations that the metal-on-metal design of the M2a Magnum hip has a propensity to generate high levels of metal ions, cause metallosis in the surrounding tissue and/or fail prematurely.
Metal-on-metal hip implants, like the Biomet M2a Magnum, are currently the subject of a U.S. Food & Drug Administration (FDA) safety review. On January 17th, the FDA proposed an order requiring manufacturers of metal-on-metal total hip replacement systems to submit premarket approval (PMA) applications, which would make them ineligible for 510(k) clearance. The agency has also recommended that doctors consider metal ion testing for all-metal hip replacement patients who are experiencing symptoms of a metal-on-metal hip implant failure, including pain, swelling, loosening of the implant, or change in the ability to walk.*
Individuals who have allegedly suffered metallosis, hip implant failure, and other serious complications as a result of a the M2a Magnum hip may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. To learn more about filing a Biomet hip lawsuit, please visit Bernstein Liebhard’s website. For additional information, contact one of our attorneys today by calling 800-511-5092.
About Bernstein Liebhard
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414 Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP